![]() |
市場調查報告書
商品編碼
2026867
醫療保健領域認知功能評估與訓練市場:2034 年預測-按組成部分、評估方法、應用、最終用戶和地區分類的全球分析Cognitive Assessment & Training In Healthcare Market Forecasts to 2034 - Global Analysis By Component, Assessment, Application, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球醫療保健領域的認知功能評估和訓練市場規模將達到 67 億美元,並在預測期內以 25.6% 的複合年成長率成長,到 2034 年將達到 417 億美元。
認知評估和訓練在醫療保健中發揮著至關重要的作用,用於評估和改善認知功能。這些工具能夠幫助臨床醫生識別和解決認知障礙,並深入了解患者的心理健康狀況。將這些工具整合到醫療保健中,有助於早期發現認知衰退,並實現個人化干涉。這有助於更有效地患者照護,並更好地管理失智症和其他認知障礙等疾病。
根據阿茲海默症協會預測,到 2050 年,患有失智症的人數將從 2019 年的 5,700 萬人增加到超過 1.53 億。
人口老化的進程
隨著老年人口的成長,對有效認知功能解決方案的需求也日益增加。這促使醫療產業將重點放在創新的評估方法和培訓項目上,以應對與老齡化相關的認知衰退、失智症和其他神經退化性疾病。市場正經歷技術進步和個人化方案的蓬勃發展,以滿足老齡化社會的特定認知需求,從而推動認知醫療保健解決方案的整體成長和發展。
資料隱私和安全問題
隨著高度敏感的患者資訊擴大被數位化用於評估,未授權存取和資料外洩風險已成為重大威脅。這些風險包括未授權存取個人健康資訊、可能損害患者隱私的潛在外洩事件,以及對強力加密措施的需求。由於這些評估通常涉及先進技術,因此確保遵守 HIPAA 等資料保護條例對於保護病患隱私和維護醫療保健生態系統的信任至關重要。
與電子健康記錄 (EHR) 整合
認知健康數據與電子病歷的無縫整合可簡化患者照護,提高診斷準確性,並促進個人化介入。這種整合使醫療服務提供者能夠利用全面的病患檔案,從而促進認知健康的整體性管理。隨著對認知健康解決方案的需求不斷成長,與電子病歷系統的整合可確保建立一個穩定且高效的醫療保健生態系統,最終改善患者預後,並推動認知健康領域的發展。
前期成本高
實施認知解決方案需要大量的資金投入,這阻礙了其在醫療機構中的廣泛應用。創建準確且經臨床檢驗的評估工具以及開發有效的培訓項目需要大量的研發投入。此外,實施安全的資料儲存方案會進一步增加初始成本。這些挑戰可能會阻礙先進認知技術的整合,並限制創新評估和培訓工具的使用。
新冠疫情的感染疾病
新冠疫情對醫療保健產生了多方面的影響。這顯著影響了醫療領域的認知功能評估和訓練市場,促使人們更加關注遠距解決方案。封鎖和社交距離的措施加速了虛擬認知功能評估和訓練平台的應用,以滿足居家醫療的需求。該行業對數位化認知健康工具的需求激增,重塑了市場格局。
在預測期內,紙筆評估細分市場預計將是最大的。
紙筆評估領域預計將迎來蓬勃發展。在醫療保健市場的認知功能評估和訓練領域,紙筆評估仍然佔據主導地位。儘管技術不斷進步,這些傳統方法仍提供了一種經濟高效且應用廣泛的認知功能評估手段。它們在基準評估和認知衰退監測中繼續發揮至關重要的作用。此外,它們在適應不斷變化的醫療保健趨勢的同時,也提高了認知功能評估的準確性和效率。
預計在預測期內,臨床試驗領域將呈現最高的複合年成長率。
預計在預測期內,臨床試驗領域將呈現最高的複合年成長率。這些試驗專注於評估和改善記憶力、注意力、問題解決能力等心理過程。在醫療保健市場,這些試驗有助於開發阿茲海默症和認知障礙等疾病的有效干預措施。認知醫療保健領域的不斷發展也持續受益於該領域持續的研發投入。
預計亞太地區將在預測期內佔據最大的市場佔有率,這主要得益於人口老化、認知健康意識的提高以及技術的進步。劍橋認知有限公司 (Cambridge Cognition Ltd.)、CogniFit Inc.、Cogstate Ltd. 和 Brain Resource Company 等領先企業均位於該地區,並正在迅速擴展其醫療保健基礎設施。政府對醫療保健基礎設施的重視以及對數位健康解決方案的採用,也進一步推動了市場的發展。
由於用於評估和改善認知功能的創新技術日益普及,預計北美地區在預測期內將呈現最高的複合年成長率。隨著市場日益關注神經系統疾病的治療和心理健康的提升,個人化、技術主導解決方案的需求也隨之激增。該地區的領導者正積極與醫療服務提供者合作,提供先進的認知評估工具和培訓項目,有助於改善患者的整體治療效果,並推動神經認知醫學實踐的發展。
According to Stratistics MRC, the Global Cognitive Assessment & Training in Healthcare Market is accounted for $6.7 billion in 2026 and is expected to reach $41.7 billion by 2034 growing at a CAGR of 25.6% during the forecast period. Cognitive assessment and training play crucial roles in healthcare, evaluating and enhancing cognitive functions. These tools help clinicians identify and address cognitive impairments, providing insights into patients' mental health. Integrating these tools into healthcare facilitates early detection of cognitive decline and enables personalized interventions, contributing to more effective patient care and management of conditions like dementia and other cognitive disorders.
According to Alzheimer's Association, more than 153 million individuals will develop dementia by 2050, up from 57 million in 2019.
Increasing aging population
As the elderly demographic expands, there is a growing demand for effective cognitive health solutions. This has prompted the healthcare industry to focus on innovative assessments and training programs to address age-related cognitive decline, dementia, and other neurodegenerative disorders. The market is witnessing an upsurge in technological advancements and personalized approaches to cater to the specific cognitive needs of the aging population, driving the overall growth and development of cognitive healthcare solutions.
Data privacy & security concerns
Sensitive patient information is increasingly digitized for assessments, the risk of unauthorized access and data breaches poses a substantial threat. Issues include unauthorized access to personal health information, potential breaches compromising patient confidentiality, and the need for robust encryption measures. As these assessments often involve advanced technologies, ensuring compliance with data protection regulations, such as HIPAA, becomes crucial to safeguarding patient privacy and maintaining trust in the healthcare ecosystem.
Integration with electronic health records (EHR)
Seamless connectivity between cognitive health data and EHR streamlines patient care, enhances diagnostic accuracy, and facilitates personalized interventions. This integration enables healthcare providers to leverage comprehensive patient profiles, fostering a holistic approach to cognitive well-being. As the demand for cognitive health solutions grows, aligning with EHR systems ensures a cohesive and efficient healthcare ecosystem, ultimately improving patient outcomes and advancing the field of cognitive healthcare.
High initial costs
Implementing cognitive solutions requires substantial financial investment, hindering widespread adoption among healthcare providers. The creation of accurate and clinically validated assessments, along with the development of effective training programs, demands substantial research and development investments. Also, implementing secure data storage further contributes to the initial expenses. This challenge may impede the integration of advanced cognitive technologies, limiting access to innovative assessment and training tools.
Covid-19 Impact
The covid-19 pandemic has had multifaceted effects on healthcare. It significantly impacted the Cognitive Assessment and Training in Healthcare Market, with increased focus on remote solutions. Lockdowns and social distancing measures accelerated the adoption of virtual platforms for cognitive assessments and training, addressing the need for at-home healthcare. The industry witnessed a surge in demand for digital cognitive health tools, reshaping the market landscape.
The pen & paper based assessment segment is expected to be the largest during the forecast period
The pen & paper based assessment segment is estimated to have a lucrative growth. Pen and paper-based assessments remain prevalent in the Cognitive Assessment and Training sector within the Healthcare market. Despite technological advancements, these traditional methods offer a cost-effective and widely accessible means of evaluating cognitive functions. They continue to play a crucial role in baseline assessments and monitoring cognitive decline. It enhances accuracy and efficiency in cognitive evaluations while adapting to evolving healthcare trends.
The clinical trials segment is expected to have the highest CAGR during the forecast period
The clinical trials segment is anticipated to witness the highest CAGR growth during the forecast period. These trials focus on assessing and improving mental processes such as memory, attention, and problem-solving. In the healthcare market, they contribute to the development of effective interventions for conditions like Alzheimer's and cognitive impairments. The evolving landscape of cognitive healthcare continues to benefit from ongoing research and innovation in this field.
Asia Pacific is projected to hold the largest market share during the forecast period owing to the increasing aging population, rising awareness of cognitive health, and technological advancements. The region is home for key players such as Cambridge Cognition Ltd., CogniFit Inc., Cogstate Ltd. and Brain Resource Company. These companies are rapidly expanding their healthcare infrastructure. Government's focus on healthcare infrastructure and the adoption of digital health solutions further drive the market.
North America is projected to have the highest CAGR over the forecast period, owing to increasing adoption of innovative technologies for cognitive evaluation and enhancement. With a focus on addressing neurological disorders and promoting mental well-being, the market has witnessed a surge in demand for personalized, technology-driven solutions. Key players in the region are actively collaborating with healthcare providers to deliver advanced cognitive assessment tools and training programs, contributing to the overall improvement of patient outcomes and the advancement of neurocognitive healthcare practices.
Key players in the market
Some of the key players profiled in the Cognitive Assessment & Training in Healthcare Market include Cambridge Cognition Ltd, CogniFit Inc, Cogstate Ltd, Eisai Limited, Brain Resource Company, WIRB-Copernicus Group, MedAvante Inc, Quest Diagnostics Incorporated, ProPhase LLC, Signant Health, Linus Health, Posit Science, Clario, Cognetivity Neurosciences, Pear Therapeutics, Akili Interactive Labs and CNS Vital Signs LLC.
In May 2023, Linus Health, a digital health solution provider, announced the result of its digital cognitive assessment solution study with a commonly used, paper-based cognitive test, the Mini-Mental State Examination (MMSE), in detecting cognitive cases of impairment. This solution helps in the earlier identification of cognitive issues.
In January 2022, Eisai Limited announced the launch of CogMate by its Taiwanese and Hong Kong subsidiaries. CogMate is a digital tool for self-assessment of brain health and is expected to be launched in other countries including Singapore.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.